Peer Review History

Original SubmissionJanuary 15, 2024
Decision Letter - Yaodong Gu, Editor

PONE-D-23-41748Implementing the Patient Partnership Approach to Quality Improvement of Care and Services: A Multiple Case Study ProtocolPLOS ONE

Dear Dr. Deslauriers,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 08 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Yaodong Gu

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in the Acknowledgments Section of your manuscript: 

"This work is being conducted as part of the first author’s PhD thesis. She gratefully acknowledges the financial support of the Research Center of the Institut universitaire de santé mentale de Montréal for the writing of this manuscript."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. 

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: 

"The first author (TD) is supported by a scholarship from the Canadian Institutes of Health Research (CIHR) grant obtained by the directors (BV, IG) (https://cihr-irsc.gc.ca/, no: 159486). The funders did not and will not have a role in study design, data collection, analysis, decision to publish, or preparation of manuscripts."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

3. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.

4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

Additional Editor Comments:

The main contribution of this study shall be pointed out in the discussion.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Partly

Reviewer #2: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Review comment

This manuscript entitled “Implementing the Patient Partnership Approach to Quality Improvement of Care and Services: A Multiple Case Study Protocol” primarily aimed to present the protocol of a multiple case study that is being conducted to document how this approach was implemented in different large healthcare organizations in Quebec. There are still some problems that cannot up this study to a publishing level. Some suggestions are listed in the specific comments below.

Specific comments:

1. What is the relationship between the multiple case study protocol proposed by the authors and the “Framework for the partnership approach between patients, their families and health and social service stakeholders” published by Quebec’s Ministry of Health and Social Services? Please further emphasise.

2. Given the relevance to the framework, is the current protocol limited to implementation in Quebec? I would recommend that the authors clarify this further in the manuscript (e.g., in the discussion section).

3. “Twelve to 15 key respondents will be recruited for each case”, how was the number of subjects determined?

4. Please provide the full name of the abbreviations when they first appear in the manuscript, e.g., here: “non-participant observations of the meetings of the QI committee engaging PFPs and”. The abbreviation “PFP” is not reasonably defined.

5. “This study will provide a better understanding of how healthcare organizations…”, I would suggest that the authors further enhance the discussion in the abstract section as it is unclear and does not provide information on the significant advantages of the current multiple case study protocol.

6. The research objectives proposed by the authors seem to be overstated, for example, “Analyze the adoption, fidelity and penetration of implementation of the partnership approach in QI within healthcare organizations.”

7. In the methods section, lengthy explanations of some basic research concepts (e.g., “case studies” and “case”) are unnecessary; please simplify them further.

8. In the semi-structured individual interviews, what was the basis for developing the relevant questions in the interview guides?

9. “In addition, since the coding step will be performed mainly by the first student-researcher, bimonthly meetings will be held with the research team…”, please provide more details about the data analysis section, especially the steps involving data coding. How was it implemented?

10. In the rigorous design of the case study, “Its credibility will be strengthened by triangulating the data collection methods (interviews, observations, document analysis) and debriefing the members of the research team during data interpretation via bi-weekly meetings”, How can the credibility of this study be enhanced through “bi-weekly meetings”?

11. In the discussion section, the potential contribution on the project needs to be further strengthened.

Reviewer #2: Review comment

This manuscript entitled “Implementing the Patient Partnership Approach to Quality Improvement of Care and Services: A Multiple Case Study Protocol” primarily aimed to explore how the partnership approach with patients and families is implemented in Quebec's healthcare organizations, following the province's guidelines. The results of this study provide guidance for publilc health. While it is a very interesting topic. But I think this manuscript has a lot of flaws to fill in before it can be published in a journal. There are several questions should be addressed, which list below. I give a minor revision for this manuscript.

Specific comments

1. In the Summary part, "However, while this framework provides guidelines by describing each partner’s role and the ways in which patient and family partners should be engaged in QI processes, it remains unclear how these recommendations were actually used and implemented by different healthcare organizations." Could you elaborate on the specific gaps or uncertainties in the implementation of the guidelines within healthcare organizations that this study aims to explore?

2. "Patient-centered approaches have emerged in healthcare organizations seeking to move away from paternalistic approaches and encourage more active participation from patients, families, and communities as partners in the healthcare system." What are the theoretical frameworks or models that underpin the transition from paternalistic to patient-centered care in the context of QI processes, and how have these models been evaluated for effectiveness in previous studies?

3. "This qualitative multiple case study will be conducted in four large healthcare organizations in Quebec. Twelve to 15 key respondents will be recruited for each case." What criteria were used to select these healthcare organizations and respondents, and how do these criteria ensure a comprehensive understanding of the patient partnership approach across different organizational contexts?

4. "This study will provide a better understanding of how healthcare organizations successfully engage PFPs in QI processes in different organizational contexts..." Based on preliminary insights or existing literature, what are the anticipated challenges in engaging patient and family partners in QI processes, and how might this study's findings contribute to overcoming these challenges?

5. In the Introduction part, “These include strategic support, the presence of leaders, the presence of formal processes and financial resources.” Please add a reference to support this sentence.

6. “It helps establish the necessary infrastructure and promote a change in attitudes and culture to one that is favorable to patient engagement” Please provide a more detailed description of how to address barriers to patient participation, for example, How to Avoid" No Show" to Planned Appointments?

Musa, S., Al Baker, W., Al Muraikhi, H., Nazareno, D., Al Naama, A., & Dergaa, I. (2021). Wellness Program Within Primary Health Care: How to Avoid" No Show" to Planned Appointments? -A Patient-Centred Care Perspective. Physical Activity & Health (2515-2270), 5(1).

7. “For their part, the program departments are responsible for implementing the partnership approach in organizational and clinical practices, including QI.” The reviewer suggested that the author provide a more detailed description of the partnership approach.

8. In the Methods part, “It therefore lends itself well to the study of management practices designed to promote partnerships with patients and their families.” Please add a reference to support this sentence.

9. In the Conclusion part, Please show detailed findings about this manuscript as well as what are the contributions for future clinical or scientific research.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Zixiang Gao

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Response to Reviewers

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

The entire manuscript has been revised to follow the manuscript body formatting guidelines.

2. Thank you for stating the following in the Acknowledgments Section of your manuscript:

"This work is being conducted as part of the first author’s PhD thesis. She gratefully acknowledges the financial support of the Research Center of the Institut universitaire de santé mentale de Montréal for the writing of this manuscript."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

"The first author (TD) is supported by a scholarship from the Canadian Institutes of Health Research (CIHR) grant obtained by the directors (BV, IG) (https://cihr-irsc.gc.ca/, no: 159486). The funders did not and will not have a role in study design, data collection, analysis, decision to publish, or preparation of manuscripts."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

My amended statements have been included in my cover letter.

3. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.

My amended statements have been included in my cover letter.

4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

My ethics statement appears at the end of the "Methods" section of my manuscript and does not appear in any other section.

Additional Editor Comments:

The main contribution of this study shall be pointed out in the discussion.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Reviewer #1: Review comment

This manuscript entitled “Implementing the Patient Partnership Approach to Quality Improvement of Care and Services: A Multiple Case Study Protocol” primarily aimed to present the protocol of a multiple case study that is being conducted to document how this approach was implemented in different large healthcare organizations in Quebec. There are still some problems that cannot up this study to a publishing level. Some suggestions are listed in the specific comments below.

Specific comments:

1. What is the relationship between the multiple case study protocol proposed by the authors and the “Framework for the partnership approach between patients, their families and health and social service stakeholders” published by Quebec’s Ministry of Health and Social Services? Please further emphasise.

The Reference Framework (Cadre de référence de l’approche de partenariat entre les usagers, leurs proches et les acteurs du système de santé et de services sociaux) is one of two reference frameworks guiding the conduct of this study, more specifically for objectives 1 and 2. This Framework was published by the Quebec Health and Social Services Ministry in 2018 to support the implementation of the partnership approach within the organizations (CI[U]SSS) of the health and social services network.

The conclusions drawn from this study will allow us, among other things, to formulate recommendations to the Ministry on how the framework could be improved and how organizations can be supported to improve engagement of PFPs in QI.

2. Given the relevance to the framework, is the current protocol limited to implementation in Quebec? I would recommend that the authors clarify this further in the manuscript (e.g., in the discussion section).

Our study has several other potential contributions that will not be limited to the Quebec context.

As mentioned in the Rigorous design of the case study section, detailed and fulsome descriptions of each case and its context will make it possible to determine the transferability of the results to other contexts. Readers will thus be able to make informed decisions about the applicability of the results to their specific context.

There are other reference frameworks in other Canadian provinces, e.g. Ontario’s Engagement Patient Framework (https://www.hqontario.ca/Portals/0/documents/pe/ontario-patient-engagement-framework-en.pdf) and elsewhere in the world, e.g. in Europe: Patient Partnership Framework for the European Reference Networks (https://download2.eurordis.org/ern/Patient-Partnership-Framework/2023/PPF.pdf) and in Australia: Consumer, Carer and Community Engagement Framework and Best Practice Guide 2022-2024 (https://www.seslhd.health.nsw.gov.au/sites/default/files/groups/Planning_Population_and_Equity/docs/Consumer_SESLHD_Digital.pdf). These reference frameworks have points of similarity that will make the results transferable.

This point has been clarified in the manuscript, in the discussion section, as suggested.

3. “Twelve to 15 key respondents will be recruited for each case”, how was the number of subjects determined?

Twelve to 15 respondents was considered an average target number of interviews sufficient to gather relevant information for each case (Malterud, Siersma & Guassora, 2016). However, it is difficult to confirm the exact number of interviews required. It is important for the research team to remain flexible to decrease or increase the number of interviews to document in sufficient depth the implementation used for each case.

4. Please provide the full name of the abbreviations when they first appear in the manuscript, e.g., here: “non-participant observations of the meetings of the QI committee engaging PFPs and”. The abbreviation “PFP” is not reasonably defined.

The abbreviation PFPs stands for patient and family partners. It was first defined in the introduction section. It is also defined in Table 1. It has been added to the title Non-participant observations during meetings of the QI committee engaging patient and family partners (PFPs) as suggested.

5. “This study will provide a better understanding of how healthcare organizations…”, I would suggest that the authors further enhance the discussion in the abstract section as it is unclear and does not provide information on the significant advantages of the current multiple case study protocol.

The discussion in the summary section has been improved.

See lines 50 – 55: The multiple cases included will allow for comparisons between different ways of engaging PFPs in QI processes within an organization, the factors influencing these practices, their advantages and disadvantages, and their implementation outcomes.

6. The research objectives proposed by the authors seem to be overstated, for example, “Analyze the adoption, fidelity and penetration of implementation of the partnership approach in QI within healthcare organizations.”

It was clarified that research objective will be achieved only for the four cases included in the study.

7. In the methods section, lengthy explanations of some basic research concepts (e.g., “case studies” and “case”) are unnecessary; please simplify them further.

In the methods section, some basic research concepts (e.g., “case studies”, “constructivist research paradigm” and “case”) have been simplified.

8. In the semi-structured individual interviews, what was the basis for developing the relevant questions in the interview guides?

Two interview guides have been developed – one for use with healthcare system stakeholders and the other, with PFPs – based on two conceptual frameworks (the Reference Framework (Cadre de référence de l’approche de partenariat entre les usagers, leurs proches et les acteurs du système de santé et de services sociaux) and the Multi-level framework predicting implementation outcomes). The questions in both guides are similar. The questions in the PFP guide have been simplified with the help of the patient co-researcher. The questions are divided to address all four objectives, i.e. vision (e.g. definition of the partnership approach, priority given by the organization, etc.), implementation (recruitment process, training, etc.), influencing factors (5 categories: innovation, patient, provider, organizational and structural) and outcomes (adoption, fidelity and penetration).

9. “In addition, since the coding step will be performed mainly by the first student-researcher, bimonthly meetings will be held with the research team…”, please provide more details about the data analysis section, especially the steps involving data coding. How was it implemented?

More details have been added to the data analysis section, especially the steps involving data coding, as suggested.

10. In the rigorous design of the case study, “Its credibility will be strengthened by triangulating the data collection methods (interviews, observations, document analysis) and debriefing the members of the research team during data interpretation via bi-weekly meetings”, How can the credibility of this study be enhanced through “bi-weekly meetings”?

The sentence on triangulation has been modified to clarify this justification. Debriefing has been removed from the sentence.

11. In the discussion section, the potential contribution on the project needs to be further strengthened.

The potential contribution to the project has been strengthened. See the discussion section.

Reviewer #2: Review comment

This manuscript entitled “Implementing the Patient Partnership Approach to Quality Improvement of Care and Services: A Multiple Case Study Protocol” primarily aimed to explore how the partnership approach with patients and families is implemented in Quebec's healthcare organizations, following the province's guidelines. The results of this study provide guidance for publilc health. While it is a very interesting topic. But I think this manuscript has a lot of flaws to fill in before it can be published in a journal. There are several questions should be addressed, which list below. I give a minor revision for this manuscript.

Specific comments:

1. In the Summary part, "However, while this framework provides guidelines by describing each partner’s role and the ways in which patient and family partners should be engaged in QI processes, it remains unclear how these recommendations were actually used and implemented by different healthcare organizations." Could you elaborate on the specific gaps or uncertainties in the implementation of the guidelines within healthcare organizations that this study aims to explore?

The Reference Framework suggests a possible distribution of roles and responsibilities among the different departments and stakeholders in the network establishments. For example, the partnership offices are responsible for supporting the recruitment and orientation of PFPs who are interested in becoming partners with their CI[U]SSS. These offices are also responsible for training and coaching these individuals, and for constantly managing a ‘bank’ of PFPs trained to act as partners. But how PFPs are recruited, trained, etc., we don't know yet. Our study seeks to better understand these processes.

2. "Patient-centered approaches have emerged in healthcare organizations seeking to move away from paternalistic approaches and encourage more active participation from patients, families, and communities as partners in the healthcare system." What are the theoretical frameworks or models that underpin the transition from paternalistic to patient-centered care in the context of QI processes, and how have these models been evaluated for effectiveness in previous studies?

A framework frequently published in the literature is Carman and colleagues' (2013) Multidimensional Framework For Patient And Family Engagement In Health And Health Care. Carman’s framework was influenced by the continuum of public participation in governance Arnstein’s “ladder of citizen participation” (Arnstein, 1969). Carman’s continuum of engagement conceptualizes patient engagement as an active partnership between patients, families or their representatives and healthcare professionals aimed at improving healthcare at three levels: individual care, organization and policy. Subsequently, the Université de Montréal drew inspiration from Carman's framework (2013) to create the Montreal Model (Pomey et al. 2015). Like Carman and colleagues (2013), the Montreal Model engages patients and their families in the individual care, organization and policy, but also in education and research.

A cluster randomized trial by Boivin and colleagues (2014) tested the impact of involving patients in setting healthcare improvement priorities for chronic care at the community level. Their conclusions report that patient involvement can change priorities driving healthcare improvement at the population level.

The systematic review by Bombard and colleagues (2018) investigated patient engagement in improving quality of care. This review identified several effective strategies and contextual factors that enable optimal engagement of patients in the design, delivery, and evaluation of health services. Their conclusions report that further data is needed to understand patients' experience of the engagement process.

3. "This qualitative multiple case study will be conducted in four large healthcare organizations in Quebec. Twelve to 15 key respondents will be recruited for each case." What criteria were used to select these healthcare organizations and respondents, and how do these criteria ensure a comprehensive understanding of the patient partnership approach across different organizational contexts?

According to Stake (2005), a case study should consist of 4 to 10 cases to benefit from the advantages of this design.

This sentence has been added. See The cases in the Recruitment and sampling sub-section.

The Quebec healthcare network is divided into large care and service territories served by 22 integrated [university] health and social services centres (CI[U]SSSs). A CI[U]SSS is part of Quebec’s public healthcare network and is associated with one of its administrative regions. The size of the territory served varies from one CI[U]SSS to another. Those located in large territories must contend with a rural geographic context that can hinder accessibility to care and services. Some health and social services centres, specifically CIUSSSs, have a university affiliation. Along with this af

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Yaodong Gu, Editor

Implementing the Patient Partnership Approach to Quality Improvement of Care and Services: A Multiple Case Study Protocol

PONE-D-23-41748R1

Dear Dr. Deslauriers,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Yaodong Gu

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Well done!

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: After careful revision by the authors, this manuscript has been greatly improved and all issues have been addressed.

Reviewer #2: Thank you to the authors for their hard work. The reviewers believe that after detailed revisions, this study has reached the level required for publication.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Zixiang Gao

**********

Formally Accepted
Acceptance Letter - Yaodong Gu, Editor

PONE-D-23-41748R1

PLOS ONE

Dear Dr. Deslauriers,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Yaodong Gu

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .